John Abeles has joined CombiMatrix’s scientific advisory board.
Abeles practiced medicine in London before becoming a senior executive in Pfizer, Sterling Drug, and Revlon Health Care. He was a healthcare analyst with Kidder Peabody and later formed MedVest, a healthcare consulting firm.
Abeles received his medical degree as well as a degree in pharmacology from the University of Birmingham, UK.
Additionally, CombiMatrix has hired Shelly Gunn as a medical director for its CombiMatrix Molecular Diagnostics unit.
Gunn earned her BA and Master's degrees from TrinityUniversity. She received her MD and PhD degrees from the University of Texas Health Science Center at San Antonio Graduate School of Biomedical Sciences.